NASDAQ:RARE

Ultragenyx Pharmaceutical Stock Predictions

Healthcare > Biotechnology

Buy RARE

*Your capital is at risk

$22.41

+0.630 (+2.89%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

RARE Prediction Chart

RARE Predictions History

Latest community submissions for RARE.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Jul 23, 2020	$81.75 +3.57%	$78.93	X	96.43%	1
iHustle84 Pro	Jul 23, 2020	$80.45 +1.93%	$78.93	X	98.07%	1
NameNotImportant Pro	Apr 29, 2019	$67.51 +0.06%	$67.47	X	99.94%	10
JS Pro	Nov 3, 2016	$60.27 +14.36%	$52.70	X	85.60%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for RARE with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ULTRAGENYX PHARMACEUTICAL INC.

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by